For the study, researchers assessed prescription medication and health data on 51,000 adults obtained from surveys of providers and medical facilities conducted in 2011 and 2013. Researchers found 19 percent of the 38.6 million Americans with mood disorders are prescribed opioids, compared to approximately 5 percent of patients without mood disorders who are prescribed opioids. The data suggests 51 percent of opioid prescriptions in the U.S. are distributed to adults with mood disorders who are at a higher risk of opioid misuse, according to a report from STAT.
While the researchers couldn’t pinpoint the exact reason for the discrepancy, senior study author Brian Sites, MD, an anesthesiologist at Dartmouth-Hitchcock Medical Center, told STAT patients with mood disorders may communicate their experience with pain differently to physicians.
“If you want to come up with social policy to address the need to decrease our out-of-control opioid prescribing, this would be the population you want to study, because they’re getting the bulk of the opioids, and then they are known to be at higher risk for the bad stuff,” Dr. Sites told STAT. “We need to understand if this massive prescribing level is appropriate in actually providing benefit commensurate with the risk.”
More articles on opioids:
Librarians thrust into first-responder role amid opioid epidemic
1 in 4 Medicaid members filled an opioid prescription in 2015
Mallinckrodt partners with Massachusetts hospitals on opioid stewardship program
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
